Media Pack
News

Current Edition

Volume 16 Issue 2
 
Europe

Sanofi, Regeneron’s Libtayo hits hot streak with EU green light, NICE backing

Libtayo was the sixth player into the U.S. PD-1/PD-L1 market. (Sanofi Genzyme/Regeneron) Sanofi and Regeneron’s Libtayo is two for two in the last two days—with ...
4 July 2019 Europe | Latin America | news | North America
Continue Reading →
Europe

Comprehensive tumor profiling promises new therapeutic options for patients with advanced cancer

The WINTHER trial, NCT01856296, led by investigators from Vall d'Hebron Institute of Oncology - VHIO (Spain), Chaim Sheba Medical Center (Israel) (Raanan Berger), Gu...
2 May 2019 Europe | Latin America | MEANA Region | news | North America | Regional News
Continue Reading →
Asia Pacific

Development progress in 2018 for acute ischemic stroke drugs will fuel market growth, says GlobalData

Activase (alteplase) is currently the only FDA-approved drug available for the treatment of acute ischemic stroke (AIS) in the 8MM*; however, novel drugs designed to...
14 February 2019 Asia Pacific | Australasia | Europe | Latin America | MEANA Region | news | North America | Regional News | Russia/Eastern Europe | Scandinavia | South Africa | Sub Saharan Africa
Continue Reading →
Asia Pacific

Brand new type of cancer drug has potential to fill unmet needs in oncology market, says GlobalData

Following a study published in The Lancet Oncology regarding a brand new type of cancer drug that has shown promise in multiple cancer types in early Phase I/II tria...
14 February 2019 Asia Pacific | Australasia | Europe | Latin America | MEANA Region | news | North America | Regional News | Russia/Eastern Europe | Scandinavia | South Africa | Sub Saharan Africa
Continue Reading →
Asia Pacific

Despite recent setbacks, the ophthalmology market still offers vast potential, says GlobalData

Despite the ophthalmology market experiencing several research and development (R&D) setbacks during 2018, the launch of three new drugs highlights that the mark...
12 February 2019 Asia Pacific | Australasia | Europe | Latin America | MEANA Region | news | North America | Regional News | Russia/Eastern Europe | Scandinavia | South Africa | Sub Saharan Africa
Continue Reading →
Asia Pacific

Servier and Galapagos announce start of global ROCCELLA Phase 2 clinical trial with S201086/GLPG1972 in osteoarthritis

Servier, an independent international pharmaceutical company, and the company Galapagos NV announce the start of a global Phase 2 trial with S201086/GLPG1972 in knee...
3 October 2018 Asia Pacific | Europe | Latin America | news | North America | Regional News
Continue Reading →
Asia Pacific

Addressing social and cultural drivers of type 2 diabetes is key to its treatment and prevention

Berlin, Germany, 2 October 2018 - New research shows healthcare services and public health strategies aimed at reducing the burden of type 2 diabetes may prove ineffe...
3 October 2018 Asia Pacific | Europe | Latin America | news | Regional News
Continue Reading →
Asia Pacific

GamaMabs Pharma starts a phase 2 study of monoclonal antibody GM102 in patients with advanced or metastatic colorectal cancer

C201 phase 2 will study immuno-enhancer antibody GM102, targeting AMHRII as a single agent and in combination with Trifluridine/Tipiracil (Lonsurf®) Paris and Toulou...
20 September 2018 Asia Pacific | Europe | Latin America | news | North America | Regional News
Continue Reading →
Europe

Innovative technique converts white fat to brown fat

Brown fat tissue in the body can burn enormous amounts of energy to generate heat, and studies in humans and animals have suggested that increasing the amount of heal...
7 August 2018 Europe | Latin America | news
Continue Reading →
Asia Pacific

HUJI gets an ultra-high resolution U-CT system

The researchers at Blum Lab will be using the MILabs’ ultra-high resolution CT to detect novel gold labeled probes in cancerous tissue as well as in atherosclerotic p...
7 August 2018 Asia Pacific | Australasia | Europe | Latin America | news | Regional News
Continue Reading →
 

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2024, All Rights Reserved – Powered by Teksyte